title: Development of polysaccharide-based colon targeted drug delivery systems for the treatment of amoebiasis.
abstract: The main focus of this study is to develop colon targeted drug delivery systems for metronidazole (MTZ). Tablets were prepared using various polysaccharides or indigenously developed graft copolymer of methacrylic acid with guar gum (GG) as a carrier. Various polysaccharides such as GG, xanthan gum, pectin, carrageenan, beta-cyclodextrin (CD) or methacrylic acid-g-guar (MAA-g-GG) gum have been selected and evaluated. The prepared tablets were tested in vitro for their suitability as colon-specific drug delivery systems. To further improve the colon specificity, some selected tablet formulations were enteric coated with Eudragit-L 100 to give protection in an acidic environment. Drug release studies were performed in simulated gastric fluid (SGF) for 2 hr followed by simulated intestinal fluid (SIF) at pH 7.4. The dissolution data demonstrate that the rate of drug release is dependent upon the nature and concentration of polysaccharide/polymer used in the formulations. Uncoated tablets containing xanthan gum or mixture of xanthan gum with graft copolymer showed 30-40% drug release during the initial 4-5 hr, whereas for tablets containing GG with the graft copolymer, it was 70%. After enteric coating, the release was drastically reduced to 18-24%. The other polysaccharides were unable to protect drug release under similar conditions. Preparations with xanthan gum as a matrix showed the time-dependent release behavior. Further, in vitro release was performed in the dissolution media with rat caecal contents. Results indicated an enhanced release when compared to formulations studied in dissolution media without rat caecal contents, because of microbial degradation or polymer solubilization. The nature of drug transport was found to be non-Fickian in case of uncoated formulations, whereas for the coated formulations, it was found to be super-Case-II. Statistical analyses of release data indicated that MTZ release is significantly affected by the nature of the polysaccharide used and enteric coating of the tablet. Differential scanning calorimetry indicated the presence of crystalline nature of drug in the formulations.
authors: Department of Chemistry, Center of Excellence in Polymer Science, Karnatak University, Dharwad, India.
authors: Raghavendra C
authors: RC
authors: Mundargi
authors: Sangamesh A
authors: SA
authors: Patil
authors: Sunil A
authors: SA
authors: Agnihotri
authors: Tejraj M
authors: TM
authors: Aminabhavi
mesh_terms: D000562:Amebiasis / Q000188:drug therapy; D000818:Animals; D000981:Antiprotozoal Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D003106:Colon / Q000378:metabolism; D016503:Drug Delivery Systems / Q000379:methods*; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D011134:Polysaccharides / Q000737:chemistry*; D051381:Rats; D017208:Rats, Wistar; D013608:Tablets, Enteric-Coated
chemical_list: D000981:Antiprotozoal Agents; D011134:Polysaccharides; D013608:Tablets, Enteric-Coated; D008795:Metronidazole